NutriBand (NTRB) Cash from Operations Growth (1y) (2017 - 2026)
NutriBand (NTRB) Cash from Operations Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.87% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -28.96% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 42.76% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.58% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 151.70% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 172.77% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 56.79% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 100.14% |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 57.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 57.88% |
| Jan 31, 2026 | 40.95% |
| Oct 31, 2025 | -73.57% |
| Jul 31, 2025 | 14.93% |
| Apr 30, 2025 | -60.32% |
| Jan 31, 2025 | -72.54% |
| Oct 31, 2024 | 5.13% |
| Jul 31, 2024 | -55.13% |
| Apr 30, 2024 | -11.21% |
| Jan 31, 2024 | 11.76% |
| Oct 31, 2023 | -104.49% |
| Jul 31, 2023 | -9.54% |
| Apr 30, 2023 | -0.75% |
| Jan 31, 2023 | 33.95% |
| Oct 31, 2022 | 56.95% |
| Jul 31, 2022 | -926.21% |
| Apr 30, 2022 | -166.36% |
| Jan 31, 2022 | -1,382.25% |
| Oct 31, 2021 | -1,311.96% |
| Jul 31, 2021 | 21.05% |